Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK)
HKD 2.57
(5.76%)
HKD 2.57
(5.76%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.11 CNY | -15.38% |
| 2022 | 0.13 CNY | -38.1% |
| 2021 | 0.21 CNY | 23.53% |
| 2020 | 0.17 CNY | -32.0% |
| 2019 | 0.25 CNY | 56.25% |
| 2018 | 0.16 CNY | 96.08% |
| 2017 | 0.08 CNY | -45.6% |
| 2016 | 0.15 CNY | 7.14% |
| 2015 | 0.14 CNY | 7.69% |
| 2014 | 0.13 CNY | 30.0% |
| 2013 | 0.10 CNY | 33.51% |
| 2012 | 0.07 CNY | 72.58% |
| 2011 | 0.04 CNY | 734.62% |
| 2010 | 0.01 CNY | 150.49% |
| 2009 | -0.01 CNY | 68.79% |
| 2008 | -0.03 CNY | 20.67% |
| 2007 | -0.04 CNY | -34.19% |
| 2006 | -0.03 CNY | 27.57% |
| 2005 | -0.04 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.07 CNY | 2756.52% |
| 2024 Q1 | 0.00 CNY | -85.98% |
| 2023 Q1 | 0.01 CNY | -86.56% |
| 2023 Q2 | 0.06 CNY | 454.0% |
| 2023 FY | - CNY | -15.38% |
| 2023 Q3 | 0.02 CNY | -62.82% |
| 2023 Q4 | 0.02 CNY | -20.39% |
| 2022 Q2 | -0.04 CNY | -927.08% |
| 2022 Q4 | 0.07 CNY | -32.36% |
| 2022 FY | - CNY | -38.1% |
| 2022 Q3 | 0.11 CNY | 377.08% |
| 2022 Q1 | 0.00 CNY | -94.98% |
| 2021 FY | - CNY | 23.53% |
| 2021 Q1 | 0.00 CNY | -93.07% |
| 2021 Q2 | 0.06 CNY | 1026.53% |
| 2021 Q3 | 0.05 CNY | -16.3% |
| 2021 Q4 | 0.10 CNY | 107.14% |
| 2020 FY | - CNY | -32.0% |
| 2020 Q3 | 0.05 CNY | 8.23% |
| 2020 Q2 | 0.05 CNY | 329.85% |
| 2020 Q1 | -0.02 CNY | -115.46% |
| 2020 Q4 | 0.07 CNY | 41.4% |
| 2019 Q2 | 0.09 CNY | 841.0% |
| 2019 Q1 | 0.01 CNY | -69.14% |
| 2019 Q4 | 0.13 CNY | 333.33% |
| 2019 FY | - CNY | 56.25% |
| 2019 Q3 | 0.03 CNY | -68.12% |
| 2018 Q4 | 0.03 CNY | 0.0% |
| 2018 FY | - CNY | 96.08% |
| 2018 Q2 | 0.03 CNY | 0.0% |
| 2018 Q3 | 0.03 CNY | 14.08% |
| 2018 Q1 | 0.03 CNY | 104.32% |
| 2017 Q3 | 0.01 CNY | -48.33% |
| 2017 Q4 | 0.01 CNY | 0.0% |
| 2017 Q2 | 0.03 CNY | 0.0% |
| 2017 Q1 | 0.03 CNY | -46.52% |
| 2017 FY | - CNY | -45.6% |
| 2016 Q3 | 0.05 CNY | 102.01% |
| 2016 Q2 | 0.02 CNY | 0.0% |
| 2016 Q1 | 0.02 CNY | -47.8% |
| 2016 FY | - CNY | 7.14% |
| 2016 Q4 | 0.05 CNY | 0.0% |
| 2015 FY | - CNY | 7.69% |
| 2015 Q4 | 0.05 CNY | 0.0% |
| 2015 Q2 | 0.02 CNY | 0.0% |
| 2015 Q3 | 0.05 CNY | 121.86% |
| 2015 Q1 | 0.02 CNY | -51.58% |
| 2014 Q3 | 0.04 CNY | 125.38% |
| 2014 Q4 | 0.04 CNY | 0.0% |
| 2014 FY | - CNY | 30.0% |
| 2014 Q1 | 0.02 CNY | -47.04% |
| 2014 Q2 | 0.02 CNY | 0.0% |
| 2013 Q2 | 0.02 CNY | 153.19% |
| 2013 Q4 | 0.04 CNY | 26.96% |
| 2013 FY | - CNY | 33.51% |
| 2013 Q1 | 0.01 CNY | -69.48% |
| 2013 Q3 | 0.03 CNY | 23.11% |
| 2012 FY | - CNY | 72.58% |
| 2012 Q4 | 0.03 CNY | 45.28% |
| 2012 Q3 | 0.02 CNY | 24.71% |
| 2012 Q2 | 0.02 CNY | 193.1% |
| 2012 Q1 | 0.01 CNY | -83.29% |
| 2011 Q3 | 0.00 CNY | -39.06% |
| 2011 FY | - CNY | 734.62% |
| 2011 Q1 | -0.00 CNY | -120.78% |
| 2011 Q2 | 0.01 CNY | 500.0% |
| 2011 Q4 | 0.03 CNY | 789.74% |
| 2010 FY | - CNY | 150.49% |
| 2010 Q4 | 0.01 CNY | 1000.0% |
| 2010 Q3 | 0.00 CNY | -50.0% |
| 2010 Q2 | 0.00 CNY | 129.79% |
| 2010 Q1 | -0.00 CNY | 0.0% |
| 2009 Q2 | -0.00 CNY | 0.0% |
| 2009 FY | - CNY | 68.79% |
| 2008 FY | - CNY | 20.67% |
| 2007 FY | - CNY | -34.19% |
| 2006 FY | - CNY | 27.57% |
| 2005 FY | - CNY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 0.34 HKD | 67.647% |
| Grand Pharmaceutical Group Limited | 0.54 HKD | 79.63% |
| Extrawell Pharmaceutical Holdings Limited | -0.07 HKD | 261.29% |
| Wai Yuen Tong Medicine Holdings Limited | -0.01 HKD | 946.154% |
| Qianhai Health Holdings Limited | -0.03 HKD | 453.698% |
| Lee's Pharmaceutical Holdings Limited | 0.03 HKD | -287.324% |
| Essex Bio-Technology Limited | 0.49 HKD | 77.551% |
| Tongfang Kontafarma Holdings Limited | -0.01 HKD | 2215.385% |
| PuraPharm Corporation Limited | -0.27 HKD | 140.741% |
| SSY Group Limited | 0.44 HKD | 75.0% |
| JBM (Healthcare) Limited | 0.15 HKD | 26.667% |
| Jacobson Pharma Corporation Limited | 0.12 HKD | 8.333% |
| China Resources Pharmaceutical Group Limited | 0.68 HKD | 83.824% |